Euan Ashley on the Functional Landscape of Coding Variation in the FH Gene LDLR
Euan Ashley, Chair at Stanford Department of Medicine, Author of The Genome Odyssey, shared on LinkedIn:
”So excited about this new work from our CardioVar consortium out this week in Science Magazine led by the amazing Daniel Tabet, and Fritz Roth.
Familial hypercholesterolemia (FH) is among the most common inherited cardiovascular diseases.
It causes early heart attacks that are preventable with modern therapy and a genomics-forward strategy for family testing.
The challenge is that many variants identified by sequencing are of unclear significance.
The new science of “variant effect mapping” uses cellular biology to model all possible variants in important genes in advance, providing scientists and clinicians with estimates as to their pathogenicity.
Here, Daniel and team tested the impact of nearly all possible (~17,000) missense coding variants in the receptor for LDL (“bad cholesterol”), the gene most commonly responsible for FH.
Importantly, they tested two functional readouts: LDLR cell-surface abundance and LDL uptake.
This yielded sequence–function maps that recapitulate known biochemistry, offer functional insights, and provide evidence for interpreting clinical variants.
Further, functional scores correlated with hyperlipidemia phenotypes in prospective human cohorts and augmented polygenic scores to improve risk inference.
These sorts of maps will increasingly become central tools in our quest to understand disease-causing human genes to help patients and prevent disease.
Amazing work from Daniel, Fritz and team.
Paper.
Variant effect map review.
Cardiovar consortium.
Atlas of variant effect maps.”
Read the full article in Science.
Article: The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR
Authors: Anna Axakova, Euan Ashley, Mafalda Bourbon, Jack M. P. Castelli, Melina Claussnitzer, Elizabeth T. Cirulli, Atina G. Coté, Carmela Serio Carrero, Da Kuang, Daniel R. Tabet, Douglas M. Fowler, Iosifina Fotiadou, Aanshi Gandhi, Michael Garton, Andrew M. Glazer, Robert A. Hegele, Mohammad Majharul Islam, Jennifer J. Knapp, Joshua W. Knowles, Brett M. Kroncke, Nishka Kishore, Roujia Li, Megan C. Lancaster, Calum A. MacRae, Kenneth Matreyek, Ranim Maaieh, Victoria N. Parikh, Simon G. Pfisterer, Ashyad Rayhan, Dan M. Roden, Frederick P. Roth, Shahin Sowlati-Hashjin, Olivia Taverniti, Jochen Weile.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy